From September 21, 2022 to September 30, 2022, the company has repurchased 660,400 shares, representing 0.06% for CNY 19.99 million. With this, the company has completed the repurchase of 660,400 shares, representing 0.06% for CNY 19.99 million under the buyback announced on October 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.81 CNY | -2.44% | +3.02% | -23.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.35% | 3.22B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.